Ligand-Based Computer-Aided Drug Discovery (LB-CADD)

Ligand-Based Computer-Aided Drug Discovery (LB-CADD) Is An Approach To Drug Discovery In Which Structural And Pharmacophoric Properties Of Molecules Are Used As Input Data To Design Computer Programs That Search For Novel Small Molecules That May Be Effective Therapeutic Agents For A Given Target. LB-CADD Plays An Important Role In Helping Identify Promising Candidates For Drug Development From A Large And Complex Chemical Space. The Major Advantages Of LB-CADD Are In Its Use Of The Established Pharmacophore And In The Large Amounts Of Information It Can Integrate. A Pharmacophore Is A Set Of Structural Parameters That Describe The Ligand-Binding Profile Of The Target In A Particular Biological System, Allowing LB-CADD Software To Discern Small Molecules That Could Interact With The Target In A Favorable Manner. What Follows Is An Extensive Search Throughout Multiple Chemical Databases, Which Generate Libraries Of Potential Small Molecules That Can Lead To Highly Active Compounds. Furthermore, One Of The Unique Features Of LB-CADD Is Its Ability To Leverage Huge Volumes Of Data And Utilize Artificial Intelligence Algorithms To “Learn” From Information As It Progresses Through Each Step Of The Drug Discovery Process. Examples Of Such Algorithms Include Bayesian Networks, Clustering Algorithms, And Decision Trees. These Powerful Computational Tools Can Be Used To Systematically Analyze Large Sets Of Data And Make Predictions Based On Analysis Of Existing Data Sets. Overall, LB-CADD Provides An Efficient Platform To Rapidly Explore Promising Therapeutic Leads. Its Application Decreases The Time Taken To Discover Useful Compounds And Can Even Yield Leads Not Previously Considered. LB-CADD May Therefore Be A Valuable Tool In The Drug Discovery Process.